Two methods have been developed for the quantization of gabapentin (GBP) in human plasma. They are based on capillary electrophoresis-laser induced fluorescence detection (CE-LIF) with and without solid-phase extraction (SPE) and the derivatizing reagent 5-(4,6-dichlorotriazinyl)aminofluorescein.